AssuredPartners Boosts Stake in Amgen Amid Analyst Upgrades
AssuredPartners Investment Advisors LLC increased its stake in Amgen Inc. (NASDAQ:AMGN) by 191.2% in the second quarter, according to a recent SEC filing. The institutional investor acquired an additional 6,994 shares during this period and now owns 10,651 shares of the medical research company's stock.
The total value of AssuredPartners' holdings in Amgen is $3,857,000 at the end of the most recent quarter. This increase is part of a broader trend where several large investors have modified their holdings of AMGN. For example, Shepherd Financial Partners LLC grew its stake in Amgen by 3.8% and now owns 4,462 shares worth $1,616,000.
Analysts' views on the company are also shifting, with some upgrading their price targets and ratings. Argus raised its target from $375 to $460 and upgraded Amgen to 'Buy', citing the company's strong earnings performance and pipeline. Mizuho and Cantor Fitzgerald analysts also project further appreciation for Amgen.